June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Pleiotropic effects of Dll1-RGD in mice oxygen-induced retinopathy
Author Affiliations & Notes
  • Guorui Dou
    Ophthalmology, Xijing Hospital, Xian, China
    Developmental Biology and Medical Genetics, Fourth Military Medical University, Xian, China
  • Yusheng Wang
    Ophthalmology, Xijing Hospital, Xian, China
  • Hua Han
    Developmental Biology and Medical Genetics, Fourth Military Medical University, Xian, China
  • Xingcheng Zhao
    Developmental Biology and Medical Genetics, Fourth Military Medical University, Xian, China
  • Footnotes
    Commercial Relationships Guorui Dou, None; Yusheng Wang, None; Hua Han, None; Xingcheng Zhao, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5555. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Guorui Dou, Yusheng Wang, Hua Han, Xingcheng Zhao; Pleiotropic effects of Dll1-RGD in mice oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5555.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Recent progress highlights Notch signaling in ischemia-related ocular angiogenesis. Delta like 1(Dll1), a critical Notch ligand in vascular development, has been identified as a potential facilitator of reparative angiogenesis. Here, we construct a novel fusion protein Dll1-RGD containing RGD motif that can ligate endothelial cell (EC) integrin, to investigate its role on mice models of oxygen induced retinopathy by specific activation of Notch in EC.

Methods: Dll1-RGD fusion was manufactured in E.Coli. The specification of this recombinant to EC was observed by adherence assay. Its Notch activating activity was detected in human umbilical vein endothelial cells (HUVEC) and confirmed by the downstream genes. The role of Dll1-RGD on vascular growth was observed in neonatal C57BL/6J mice injected with Dll1-RGD subcutaneously. Bead assay, transwell chamber and tube formation were conducted to study biological behaviors of HUVEC treated by Dll1-RGD. Neonatal C57BL/6J mice was taken into 75% oxygen chamber from P7-P12 and were injected with Dll1-RGD subcutaneously on P12. The area of retinal angiogenesis was analyzed on P17.

Results: Dll1-RGD could specifically adhere to the endothelial cells. Dll1-RGD greatly enhanced Notch signaling and upregulated the Notch downstream genes in EC. In vitro, the anti-angiogenic role of Dll1-RGD was identified in the endothelial cell sprouting, migration and tube formation. In the developing retinal vascular formation, Dll1-RGD attenuated the growth of retinal vasculature, as branching loops and tip cells were greatly decreased. Specific activation of Notch by Dll1-RGD induced regrowth of retinal vessels following oxygen-induced retinopathy on P17. Pleiotropically, it prevented the formation of preretinal neovascular tufts, but promotes formation of intraretinal capillaries following oxygen-induced retinopathy.

Conclusions: Our data provide Dll1-RGD as a potential therapeutic strategy to ischemia-related ocular angiogenesis by enhancing Notch signaling in EC.

Keywords: 706 retinopathy of prematurity • 765 wound healing • 572 ischemia  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.